BlackRock’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $81.4M | Sell |
|
|||||
|
2025
Q1 | $80.6M | Sell |
|
|||||
|
2024
Q4 | $89.9M | Buy |
|
|||||
|
2024
Q3 | $80M | Buy |
|
|||||
|
2024
Q2 | $55.4M | Buy |
|
|||||
|
2024
Q1 | $61.2M | Buy |
|
|||||
|
2023
Q4 | $44M | Buy |
|
|||||
|
2023
Q3 | $31.2M | Sell |
|
|||||
|
2023
Q2 | $32.2M | Sell |
|
|||||
|
2023
Q1 | $40.9M | Sell |
|
|||||
|
2022
Q4 | $48.2M | Buy |
|
|||||
|
2022
Q3 | $38.6M | Sell |
|
|||||
|
2022
Q2 | $36.5M | Sell |
|
|||||
|
2022
Q1 | $47.1M | Buy |
|
|||||
|
2021
Q4 | $43.1M | Sell |
|
|||||
|
2021
Q3 | $54M | Buy |
|
|||||
|
2021
Q2 | $44.2M | Sell |
|
|||||
|
2021
Q1 | $59.3M | Sell |
|
|||||
|
2020
Q4 | $77.2M | Buy |
|
|||||
|
2020
Q3 | $70.3M | Sell |
|
|||||
|
2020
Q2 | $71.5M | Buy |
|
|||||
|
2020
Q1 | $45.1M | Sell |
|
|||||
|
2019
Q4 | $58.9M | Sell |
|
|||||
|
2019
Q3 | $43.7M | Sell |
|
|||||
|
2019
Q2 | $52.3M | Buy |
|
|||||
|
2019
Q1 | $49.8M | Sell |
|
|||||
|
2018
Q4 | $28M | Sell |
|
|||||
|
2018
Q3 | $32.7M | Buy |
|
|||||
|
2018
Q2 | $29.2M | Buy |
|
|||||
|
2018
Q1 | $26.5M | Sell |
|
|||||
|
2017
Q4 | $17.3M | Buy |
|